Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5837613 | 0.96 | TSHR (0.39) | TSHRKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL5838352 | 0.89 | TSHR (0.41) | TSHRKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL1398234 | 0.89 | TSHR (0.41) | TSHRKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL2189982 | 0.86 | TSHR (0.41) | TSHRTHRBALDH1A1 | |
| SCHEMBL5838952 | 0.86 | TSHR (0.46) | TSHRKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL5837966 | 0.81 | TSHR (0.41) | TSHRKDM4EDUSP3MEN1KMT2A | |
| Propanol SCHEMBL27929363 | 0.81 | TSHR (0.53) | TSHRKDM4EDUSP3MEN1KMT2A | |
| Propane SCHEMBL3677972 | 0.81 | TSHR (0.57) | TSHRKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL25707 | 0.81 | TSHR (0.61) | TSHRKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL16863053 | 0.81 | TSHR (0.61) | TSHRKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3220741-B1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | ROCHAL IND LLC (US) | 2021-02-24 | — | — | EP | claimed |
| EP-3220741-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | Rochal Industries, LLC (US) | 2017-09-27 | — | — | EP | claimed |
| EP-2764065-B1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL IND LLC (US) | 2017-03-22 | — | — | EP | claimed |
| WO-2016054021-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | ROCHAL INDUSTRIES, LLC (US) | 2016-04-07 | — | — | WO | claimed |
| EP-2764065-A1 | SACRIFICIAL ADHESIVE COATINGS | Rochal Industries, LLP (US) | 2014-08-13 | — | — | EP | claimed |
| WO-2013052276-A1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL INDUSTRIES, LLP (US) | 2013-04-11 | — | — | WO | claimed |
| US-8263720-B1 | Sacrificial adhesive coatings | ROCHAL INDUSTRIES, LLP (US) | 2012-09-11 | — | — | US | claimed |
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | ROCHAL TECHNOLOGIES LLC (US) | 2023-12-12 | — | — | US | disclosed |
| EP-3220741-B1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | ROCHAL IND LLC (US) | 2021-02-24 | — | — | EP | disclosed |
| EP-3052140-B1 | NON-SELF-ADHERENT COATING MATERIALS | ROCHAL IND LLC (US) | 2019-05-01 | — | — | EP | disclosed |
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | ROCHAL INDUSTRIES, LLC (US) | 2017-12-21 | — | — | US | disclosed |
| EP-3220741-A1 | COMPOSITION AND KITS FOR INHIBITION OF PATHOGENIC MICROBIAL INFECTION AND METHODS OF USING THE SAME | Rochal Industries, LLC (US) | 2017-09-27 | — | — | EP | disclosed |
| EP-2764065-B1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL IND LLC (US) | 2017-03-22 | — | — | EP | disclosed |
| US-20070129474-A1 | Solution of an amphiphilic copolymer of a nitrogen-containing monomer, such as N-isopropylacrylamide, and a siloxy monomer, preferably 3-(methacryloyloxy)propyltris(trimethylsiloxy)silane in non-stinging, volatile, siloxane, alkane, fluorocarbon, lor iquid or supercritical carbon dioxide; medical devices | ROCHAL INDUSTRIES, LLP. (US) | 2007-06-07 | — | — | US | disclosed |
| US-7037954-B2 | Ocular lens material | MENICON CO., LTD. (JP) | 2006-05-02 | — | — | US | disclosed |
| EP-1197782-B1 | MATERIAL FOR OCULAR LENS | MENICON CO LTD (JP) | 2004-06-02 | — | — | EP | disclosed |
| US-20040039077-A1 | Ocular lens material | MENICON CO., LTD. | 2004-02-26 | — | — | US | disclosed |
| US-6638991-B2 | Lens material comprising a copolymer derived from a polysiloxane endcapped with acrylated urethane groups, a silicon-containing alkyl methacrylate, a hydrophilic monomer, and a crosslinking monomer; oxygen permeability, strength | MENICON CO., LTD. (JP) | 2003-10-28 | — | — | US | disclosed |
| US-20020198280-A1 | Material for ocular lens | MENICON CO., LTD. (JP) | 2002-12-26 | — | — | US | disclosed |
| EP-1197782-A1 | MATERIAL FOR OCULAR LENS | MENICON CO., LTD. (JP) | 2002-04-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170360825-A1 | Composition and Kits for Inhibition of Pathogenic Microbial Infection and Methods of Using the Same | CUTA, MMP8, MMP1 | TSHR 3520/4885KDM4E 4848/4885DUSP3 1252/4885 |
| US-11839626-B2 | Composition and kits for inhibition of pathogenic microbial infection and methods of using the same | CUTA, MMP8, MMP1 | TSHR 3520/4885KDM4E 4848/4885DUSP3 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.